Selected article for: "multistate model and propose multistate model"

Author: Maja von Cube; Marlon Grodd; Martin Wolkewitz; Derek Hazard; Jerome Lambert
Title: Harmonizing heterogeneous endpoints in COVID-19 trials without loss of information - an essential step to facilitate decision making
  • Document date: 2020_4_3
  • ID: bsddxgx2_16
    Snippet: To obtain a detailed understanding of potential treatment effects, we propose the multistate model shown in Figure 1 For clinical trials that have already been started, we highly recommend to provide the stacked probability plots. Specifically clinical trials using the categorical endpoints recommended by the WHO R&D Blueprint expert group have all the necessary information available for this detailed analysis......
    Document: To obtain a detailed understanding of potential treatment effects, we propose the multistate model shown in Figure 1 For clinical trials that have already been started, we highly recommend to provide the stacked probability plots. Specifically clinical trials using the categorical endpoints recommended by the WHO R&D Blueprint expert group have all the necessary information available for this detailed analysis.

    Search related documents:
    Co phrase search for related documents
    • Blueprint expert and treatment effect: 1
    • Blueprint expert group and categorical endpoint: 1, 2
    • Blueprint expert group and treatment effect: 1
    • categorical endpoint and treatment effect: 1
    • clinical trial and detailed analysis: 1, 2, 3, 4, 5, 6
    • clinical trial and detailed understanding: 1
    • clinical trial and necessary information: 1, 2, 3, 4
    • clinical trial and potential treatment effect: 1, 2, 3, 4, 5
    • clinical trial and specifically clinical trial: 1, 2, 3, 4
    • clinical trial and start clinical trial: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • clinical trial and treatment effect: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
    • detailed analysis and necessary information: 1, 2, 3
    • detailed analysis and treatment effect: 1, 2, 3, 4
    • detailed understanding and multistate model: 1, 2
    • detailed understanding and necessary information: 1
    • detailed understanding and potential treatment effect: 1
    • detailed understanding and probability plot: 1
    • detailed understanding and treatment effect: 1, 2
    • multistate model and probability plot: 1, 2, 3